128
Views
2
CrossRef citations to date
0
Altmetric
Short Report

Alexithymia in Patients with Psoriasis: A Cross-Sectional Study from Ecuador

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , & show all
Pages 1121-1126 | Published online: 16 Dec 2019

References

  • Taylor GJ. Alexithymia: concept, measurement, and implications for treatment. Am J Psychiatry. 1984;141(6):725–732.6375397
  • Lumley MA, Neely LC, Burger AJ. The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J Pers Assess. 2007;89(3):230–246. doi:10.1080/0022389070162969818001224
  • Lumley MA, Stettner L, Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res. 1996;41(6):505–518. doi:10.1016/S0022-3999(96)00222-X9032714
  • Kojima M. Alexithymia as a prognostic risk factor for health problems: a brief review of epidemiological studies. Biopsychosoc Med. 2012;6(1):21. doi:10.1186/1751-0759-6-2123244192
  • Sampogna F, Puig L, Spuls P, et al. Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study. Br J Dermatol. 2017;176(5):1195–1203. doi:10.1111/bjd.1524327995617
  • Korkoliakou P, Christodoulou C, Kouris A, et al. Alexithymia, anxiety and depression in patients with psoriasis: a case-control study. Ann Gen Psychiatry. 2014;13(1):38. doi:10.1186/s12991-014-0038-725520742
  • Innamorati M, Quinto RM, Imperatori C, et al. Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis. Compr Psychiatry. 2016;70:200–208. doi:10.1016/j.comppsych.2016.08.00127565774
  • Luminet O, Bagby RM, Taylor GJ. Alexithymia: Advances in Research, Theory, and Clinical Practice. Cambridge University Press; 2018.
  • Sampogna F, Puig L, Spuls P, et al. Reversibility of alexithymia with effective treatment of moderate‐to‐severe psoriasis: longitudinal data from EPIDEPSO. Br J Dermatol. 2019;180(2):397–403. doi:10.1111/bjd.2019.180.issue-230269346
  • Misery L. Alexithymia and psoriasis: what is the link? Br J Dermatol. 2019;180(2):261. doi:10.1111/bjd.2019.180.issue-230714112
  • Korkoliakou P, Efstathiou V, Giannopoulou I, et al. Psychopathology and alexithymia in patients with psoriasis. An Bras Dermatol. 2017;92(4):510–515. doi:10.1590/abd1806-4841.2017566028954100
  • Larsen MH, Krogstad AL, Wahl AK. Alexithymia, illness perception and self-management competency in psoriasis. Acta Derm Venereol. 2017;97(8–9):934–940. doi:10.2340/00015555-270728536730
  • Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278–285.28404701
  • Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto alexithymia scale—I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38(1):23–32. doi:10.1016/0022-3999(94)90005-18126686
  • Taylor GJ, Bagby RM, Parker JD. The 20-item Toronto alexithymia scale: IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res. 2003;55(3):277–283. doi:10.1016/S0022-3999(02)00601-312932803
  • Fredriksson T, Pettersson U. Severe psoriasis–oral therapy with a new retinoid. Dermatologica. 1978;157(4):238–244. doi:10.1159/000250839357213
  • Ashcroft DM, Po WAL, Williams HC, Griffiths CE. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol. 1999;141(2):185–191. doi:10.1046/j.1365-2133.1999.02963.x10468786
  • Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303(1):1–10. doi:10.1007/s00403-010-1080-120857129
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-000073945130
  • Baiardini I, Abba S, Ballauri M, Vuillermoz G, Braido F. Alexithymia and chronic diseases: the state of the art. G Ital Med Lav Ergon. 2011;33(1Suppl A):A47–A52.21488483
  • Chimenti MS, Fonti GL, Conigliaro P, et al. Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: a cross-sectional study. Medicine. 2019;98(4):e13955. doi:10.1097/MD.000000000001395530681555
  • Talamonti M, Galluzzo M, Servoli S, D’Adamio S, Bianchi L. Alexithymia and plaque psoriasis: preliminary investigation in a clinical sample of 250 patients. Dermatology. 2016;232(6):648–654. doi:10.1159/00045366128152541
  • Masmoudi J, Maalej I, Masmoudi A, et al. Alexithymia and psoriasis: a case-control study of 53 patients. L’Encephale. 2009;35(1):10–17. doi:10.1016/j.encep.2007.11.009
  • Torres-Hernández M, López-García S, Pedroza-Escobar D, Escamilla-Tilch M. El papel de la alexitimia como factor psicosomático en la psoriasis. Rev Med Inst Mex Seguro Soc. 2015;53(3):268–272.25984610
  • Taylor GJ, Bagby RM, Parker JD. Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge University Press; 1999.
  • Nemiah JC. Denial revisited: reflections on psychosomatic theory. Psychother Psychosom. 1975;26(3):140–147. doi:10.1159/0002869231215451
  • Pasini A, Delle Chiaie R, Seripa S, Ciani N. Alexithymia as related to sex, age, and educational level: results of the Toronto alexithymia scale in 417 normal subjects. Compr Psychiatry. 1992;33(1):42–46. doi:10.1016/0010-440X(92)90078-51555409
  • Aneshensel CS, Phelan JC, Bierman A. Handbook of the Sociology of Mental Health. Springer; 1999.